We are live on
!
Find out more
YF
Yu Fan Portfolio holdings
AUM
$97M
1-Year Est. Return
57.2%
This Fund
S&P 500
This Quarter
Est. Return
-13.39%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$6.46M
AUM Growth
-$930K
(-13%)
Cap. Flow
+$575K
Cap. Flow
% of AUM
8.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Castle Biosciences
CSTL
|
+$478K |
| 2 |
Prenetics Global
PRE
|
+$119K |
Top Sells
| 1 |
CervoMed
CRVO
|
+$22K |
Sector Composition
| 1 | Financials | 75.99% |
| 2 | Healthcare | 22.44% |
| 3 | Consumer Staples | 1.56% |
Similar funds
PWM
ACM
AWP
SFO
CSW
TFS
FA
JKSF
Yu Fan's Q2 2022 Portfolio in Review
As of Q2 2022, Yu Fan held 6 positions worth $6.46M, down 13% from $7.39M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Yu Fan deployed $575K of net new capital in Q2 2022, opening 2 new positions. Its largest new stake was Castle Biosciences: 20,592 shares worth $452K.
By sector, the portfolio is most concentrated in Financials at 76% of assets, up from 67% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the most notable exit was CervoMed, an estimated $22K sold.
- Yu Fan's largest Q2 2022 buy was Castle Biosciences: 20,592 shares worth $452K.
- Yu Fan fully exited CervoMed in Q2 2022, selling an estimated $22K.
- Yu Fan's ten largest holdings make up 100% of its $6.46M portfolio in Q2 2022.
- Yu Fan opened 2 new positions and closed 1 in Q2 2022.
- Yu Fan's portfolio value fell 13% quarter-over-quarter to $6.46M.
Based on Yu Fan's 13F filing for Q2 2022, filed 15 Aug 2022.